1. Home
  2. VTR vs A Comparison

VTR vs A Comparison

Compare VTR & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ventas Inc.

VTR

Ventas Inc.

N/A

Current Price

$85.29

Market Cap

41.1B

Sector

Real Estate

ML Signal

N/A

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

N/A

Current Price

$114.41

Market Cap

39.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VTR
A
Founded
1983
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
41.1B
39.8B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
VTR
A
Price
$85.29
$114.41
Analyst Decision
Buy
Buy
Analyst Count
13
16
Target Price
$84.77
$161.06
AVG Volume (30 Days)
2.7M
2.4M
Earning Date
05-05-2026
05-27-2026
Dividend Yield
2.45%
0.89%
EPS Growth
184.21
3.16
EPS
0.54
1.07
Revenue
$5,833,980,000.00
$4,472,000,000.00
Revenue This Year
$12.42
$8.42
Revenue Next Year
$8.32
$6.12
P/E Ratio
$157.17
$107.72
Revenue Growth
18.47
6.43
52 Week Low
$60.15
$96.43
52 Week High
$87.87
$160.27

Technical Indicators

Market Signals
Indicator
VTR
A
Relative Strength Index (RSI) 59.28 27.67
Support Level $66.18 $111.98
Resistance Level $87.56 $123.79
Average True Range (ATR) 1.33 3.17
MACD -0.40 -0.43
Stochastic Oscillator 35.89 3.89

Price Performance

Historical Comparison
VTR
A

About VTR Ventas Inc.

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: